Showing 1 - 20 results of 32 for search 'Faloppi, Luca', query time: 0.12s Refine Results
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients
Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

Search Tools: Get RSS Feed — Email this Search — Save Search